Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.


Strengths

● Its low valuation, with P/E ratio at 4.18 and 6.79 for the ongoing fiscal year and 2023 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The stock, which is currently worth 2022 to 0.64 times its sales, is clearly overvalued in comparison with peers.

● The company's share price in relation to its net book value makes it look relatively cheap.

● The company is one of the best yield companies with high dividend expectations.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.

● The group usually releases upbeat results with huge surprise rates.


Weaknesses

● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.

● The company's earnings growth outlook lacks momentum and is a weakness.

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● The company does not generate enough profits, which is an alarming weak point.

● The group shows a rather high level of debt in proportion to its EBITDA.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.